Furthermore, syntabulin-dependent STX1B trafficking and synaptic delivery is critical for presynaptic neurotransmitter release and E/I balance, which protects the brain from epilepsy and may be a potential therapeutic target. This evidence concerns the gene SYBU and epilepsy.